Camostat, an inhibitor of transmembrane protease serine 2 (TMPRSS2), commercially available in Japan for treatment of chronic pancreatitis and postoperative reflux esophagitis, was found to inhibit viruses such as SARS-CoV 2 [87, 88] and Gram-positive bacteria. Here, TMPRSS2 is linked to chronic pancreatitis.